España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Enfusion
ENFN
NYSE
Watchlist
Get Report
Perks
Buy
Compare Brokers
$8.77
0.19
2.21%
At Close: -
$8.77
0
0.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Enfusion (ENFN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Enfusion (NYSE:ENFN) Stock
Enfusion Stock (NYSE: ENFN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Es...
Benzinga Newsdesk
Thursday, March 14, 2024
Watching Enfusion; Spruce Point Capital Manag...
Benzinga Newsdesk
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, March 13, 2024
A Glimpse Into The Expert Outlook On Enfusion Through 4 Analysts
Benzinga Insights
B of A Securities Maintains Underperform on E...
Benzinga Newsdesk
Tuesday, March 12, 2024
Enfusion shares are trading higher after the ...
Benzinga Newsdesk
Enfusion Expects 2024 Revenue of $200M-$210M ...
Benzinga Newsdesk
Enfusion Q4 2023 Adj EPS $0.04 Misses $0.05 E...
Benzinga Newsdesk
Earnings Scheduled For March 12, 2024
Benzinga Insights
Monday, March 11, 2024
Earnings Outlook For Enfusion
Benzinga Insights
Wednesday, March 06, 2024
Major Purchase Alert: Oleg Movchan Invests $120K In Enfusion Stock
Benzinga Insights
Wednesday, February 28, 2024
Enfusion Stock To Remain Range-Bound In 2024 Amid Stable Hedge Fund Market: Goldman Sachs Analyst Downgrades Stock
Anusuya Lahiri
Goldman Sachs Downgrades Enfusion to Sell, Lo...
Benzinga Newsdesk
Tuesday, January 30, 2024
JP Morgan Downgrades Enfusion: Here's What You Need To Know
Benzinga Insights
Enfusion shares are trading lower after JP Mo...
Benzinga Newsdesk
JP Morgan Downgrades Enfusion to Underweight,...
Benzinga Newsdesk
Tuesday, January 02, 2024
This Analyst With 84% Accuracy Rate Sees Around 13% Upside In Darden Restaurants - Here Are 5 Stock Picks For 2023 From Wall Street's Most Accurate Analysts
Avi Kapoor
Wednesday, December 20, 2023
Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Enfusion Chief Executive Officer Trades $1.00M In Company Stock
Benzinga Insights
Wednesday, December 06, 2023
Insider Unloading: Oleg Movchan Sells $1.51M Worth Of Enfusion Shares
Benzinga Insights
Wednesday, November 29, 2023
Massive Insider Trade At Enfusion
Benzinga Insights
Monday, November 20, 2023
Enfusion Announces Appointment Of Neal Pawar ...
Benzinga Newsdesk
Tuesday, November 07, 2023
UBS Initiates Coverage On Enfusion with Neutr...
Benzinga Newsdesk
Enfusion Q3 EPS $0.02 Misses $0.05 Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Wednesday, August 09, 2023
Goldman Sachs Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Enfusi...
Benzinga Newsdesk
Tuesday, August 08, 2023
Enfusion shares are trading lower after the c...
Benzinga Newsdesk
Enfusion Sees FY23 Revenue $170M-$175M Vs $18...
Benzinga Newsdesk
Enfusion Q2 EPS $0.01 Misses $0.05 Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, August 07, 2023
Earnings Preview: Enfusion
Benzinga Insights
Thursday, July 13, 2023
10% Owner of Enfusion Sold $10.70M In Stock
Benzinga Insights
Monday, June 26, 2023
12 Information Technology Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Enfusion (ENFN) Stock Is Exploding Higher
Henry Khederian
Enfusion Shares Resume Trade Following Circui...
Happy Mohamed
"Enfusion's Management Has Been Approached In Recent Months By Francisco Partners, Vista Equity Partners And Investment Firm Irenic Capital Management, Said The Sources Who Asked Not To Be Identified Because The Talks Are Private"
Happy Mohamed
Enfusion shares are trading higher following ...
Bill Haddad
Enfusion Shares Halted On Circuit Breaker To ...
Benzinga Newsdesk
Enfusion Attracting Takeover Interest From Pr...
Benzinga Newsdesk
Monday, May 22, 2023
Piper Sandler Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Tuesday, May 16, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, May 15, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, May 10, 2023
Credit Suisse Maintains Neutral on Enfusion, ...
Benzinga Newsdesk
Tuesday, May 09, 2023
Enfusion shares are trading higher after the ...
Benzinga Newsdesk
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Enfusion Q1 EPS $0.04 Beats $0.03 Estimate, S...
Benzinga Newsdesk
Earnings Scheduled For May 9, 2023
Benzinga Insights
Tuesday, May 02, 2023
Watching Enfusion, Steelcase; Hearing Zacks U...
Benzinga Newsdesk
Thursday, April 06, 2023
Enfusion Announced A New Partnership With Qon...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch